These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18445344)

  • 1. Activity after site-directed mutagenesis of CD59 on complement-mediated cytolysis.
    Zhu X; Gao M; Ren S; Wang Q; Lin C
    Cell Mol Immunol; 2008 Apr; 5(2):141-6. PubMed ID: 18445344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the active site of CD59.
    Yu J; Abagyan R; Dong S; Gilbert A; Nussenzweig V; Tomlinson S
    J Exp Med; 1997 Feb; 185(4):745-53. PubMed ID: 9034152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mutations in rat CD59 that increase the complement regulatory activity.
    Hinchliffe SJ; Morgan BP
    Biochemistry; 2000 May; 39(19):5831-7. PubMed ID: 10801333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the human CD59 complement binding interface toward engineering new therapeutics.
    Huang Y; Smith CA; Song H; Morgan BP; Abagyan R; Tomlinson S
    J Biol Chem; 2005 Oct; 280(40):34073-9. PubMed ID: 16079145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
    Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
    FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel short peptide seal specific to CD59 and its effect on HeLa cell growth and apoptosis.
    Li B; Gao MH; Chu XM; Xu YJ; Yang F
    Cell Oncol (Dordr); 2012 Oct; 35(5):355-65. PubMed ID: 22945508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for a link between complement and the vascular complications of diabetes.
    Acosta J; Hettinga J; Flückiger R; Krumrei N; Goldfine A; Angarita L; Halperin J
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5450-5. PubMed ID: 10805801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9.
    Wickham SE; Hotze EM; Farrand AJ; Polekhina G; Nero TL; Tomlinson S; Parker MW; Tweten RK
    J Biol Chem; 2011 Jun; 286(23):20952-62. PubMed ID: 21507937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function.
    Rushmere NK; Tomlinson S; Morgan BP
    Immunology; 1997 Apr; 90(4):640-6. PubMed ID: 9176120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
    Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
    Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer's disease.
    Yang LB; Li R; Meri S; Rogers J; Shen Y
    J Neurosci; 2000 Oct; 20(20):7505-9. PubMed ID: 11027207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-κB and enhancer-binding CREB protein scaffolded by CREB-binding protein (CBP)/p300 proteins regulate CD59 protein expression to protect cells from complement attack.
    Du Y; Teng X; Wang N; Zhang X; Chen J; Ding P; Qiao Q; Wang Q; Zhang L; Yang C; Yang Z; Chu Y; Du X; Zhou X; Hu W
    J Biol Chem; 2014 Jan; 289(5):2711-24. PubMed ID: 24338025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of human and rat CD59 to the terminal complement complexes.
    Lehto T; Morgan BP; Meri S
    Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complement regulatory protein CD59: insights into attenuation of choroidal neovascularization.
    Schnabolk G; Tomlinson S; Rohrer B
    Adv Exp Med Biol; 2014; 801():435-40. PubMed ID: 24664728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the CD59-C9 binding interaction.
    Huang Y; Qiao F; Abagyan R; Hazard S; Tomlinson S
    J Biol Chem; 2006 Sep; 281(37):27398-404. PubMed ID: 16844690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of CD59 up-regulation induced in porcine endothelial cells by alphaGal ligation and its association with protection from complement.
    Grubbs BC; Benson BA; Dalmasso AP
    Xenotransplantation; 2003 Sep; 10(5):387-97. PubMed ID: 12950982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of mutant CD59 protein on proliferation of ovarian cancer A2780 cells].
    Li JM; Gao MH; Zhang B
    Ai Zheng; 2009 Apr; 28(4):379-83. PubMed ID: 19622297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cryptic non-GPI-anchored cytosolic isoform of CD59 controls insulin exocytosis in pancreatic β-cells by interaction with SNARE proteins.
    Golec E; Rosberg R; Zhang E; Renström E; Blom AM; King BC
    FASEB J; 2019 Nov; 33(11):12425-12434. PubMed ID: 31412214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59.
    Bodian DL; Davis SJ; Morgan BP; Rushmere NK
    J Exp Med; 1997 Feb; 185(3):507-16. PubMed ID: 9053451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of glycation of CD59 on complement-mediated cytolysis.
    Cheng Y; Gao M
    Cell Mol Immunol; 2005 Aug; 2(4):313-7. PubMed ID: 16274631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.